S&P 500   3,818.83
DOW   31,029.31
QQQ   283.80
S&P 500   3,818.83
DOW   31,029.31
QQQ   283.80
S&P 500   3,818.83
DOW   31,029.31
QQQ   283.80
S&P 500   3,818.83
DOW   31,029.31
QQQ   283.80

Celsion Stock Forecast, Price & News

+0.03 (+1.62%)
(As of 06/29/2022 04:00 PM ET)
Today's Range
50-Day Range
52-Week Range
19,252 shs
Average Volume
192,232 shs
Market Capitalization
$13.35 million
P/E Ratio
Dividend Yield
Price Target
30 days | 90 days | 365 days | Advanced Chart

Receive CLSN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Celsion and its competitors with MarketBeat's FREE daily newsletter.

CLSN Stock Forecast (MarketRank)

Overall MarketRank

2.19 out of 5 stars

Medical Sector

394th out of 1,432 stocks

Pharmaceutical Preparations Industry

167th out of 685 stocks

Analyst Opinion: 3.5Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -
Celsion logo

About Celsion (NASDAQ:CLSN)

Celsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company also has two feasibility stage platform technologies for the development of nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. Celsion Corporation was founded in 1982 and is based in Lawrenceville, New Jersey.

CLSN Stock News Headlines

CLSN: OVATION 2 Study 85% Enrolled…
StockNews.com Begins Coverage on Celsion (NASDAQ:CLSN)
Earnings Outlook For Celsion
Celsion Q4 2022 Earnings Preview
See More Headlines

Industry, Sector and Symbol

Pharmaceutical preparations
Current Symbol
Year Founded

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Price Target and Rating

Average Stock Price Forecast
High Stock Price Forecast
Low Stock Price Forecast
Forecasted Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
2 Analysts


Net Income
$-20.77 million
Net Margins
Pretax Margin


Sales & Book Value

Annual Sales
$500 thousand
Book Value
$9.66 per share


Free Float
Market Cap
$13.35 million

Social Links

Celsion Frequently Asked Questions

Should I buy or sell Celsion stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Celsion in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Celsion stock.
View analyst ratings for Celsion
or view top-rated stocks.

What is Celsion's stock price forecast for 2022?

2 analysts have issued twelve-month price targets for Celsion's shares. Their CLSN stock forecasts range from $16.00 to $16.00. On average, they expect Celsion's share price to reach $16.00 in the next year. This suggests a possible upside of 751.1% from the stock's current price.
View analysts' price targets for Celsion
or view top-rated stocks among Wall Street analysts.

How has Celsion's stock performed in 2022?

Celsion's stock was trading at $8.10 at the start of the year. Since then, CLSN stock has decreased by 76.8% and is now trading at $1.88.
View the best growth stocks for 2022 here

When is Celsion's next earnings date?

Celsion is scheduled to release its next quarterly earnings announcement on Thursday, August 11th 2022.
View our earnings forecast for Celsion

How were Celsion's earnings last quarter?

Celsion Co. (NASDAQ:CLSN) posted its earnings results on Monday, May, 16th. The biotechnology company reported ($1.82) earnings per share for the quarter, missing analysts' consensus estimates of ($0.99) by $0.83. Celsion had a negative net margin of 5,110.80% and a negative trailing twelve-month return on equity of 45.34%. During the same period last year, the firm earned ($1.35) earnings per share.
View Celsion's earnings history

When did Celsion's stock split? How did Celsion's stock split work?

Celsion's stock reverse split on the morning of Tuesday, March 1st 2022. The 1-15 reverse split was announced on Tuesday, March 1st 2022. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, March 1st 2022. An investor that had 100 shares of Celsion stock prior to the reverse split would have 7 shares after the split.

Who are Celsion's key executives?

Celsion's management team includes the following people:
  • Mr. Michael H. Tardugno, Exec. Chairman, Pres & CEO (Age 71, Pay $1.01M)
  • Mr. Jeffrey W. Church CPA, CPA, CFO, Exec. VP & Corp. Sec. (Age 65, Pay $528.54k)
  • Dr. Khursheed Anwer M.B.A., Ph.D., Exec. VP & Chief Scientific Officer (Age 62, Pay $511.92k)
  • Dr. Nicholas Borys, Exec. VP & Chief Medical Officer (Age 63, Pay $586.54k)
  • Mr. Timothy J. Tumminello, Chief Accounting Officer & Controller (Age 64)
  • Ms. Marianne M. Lambertson, VP of Communications & Investor Relations

What other stocks do shareholders of Celsion own?

What is Celsion's stock symbol?

Celsion trades on the NASDAQ under the ticker symbol "CLSN."

How do I buy shares of Celsion?

Shares of CLSN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Celsion's stock price today?

One share of CLSN stock can currently be purchased for approximately $1.88.

How much money does Celsion make?

Celsion (NASDAQ:CLSN) has a market capitalization of $13.35 million and generates $500 thousand in revenue each year.

How many employees does Celsion have?

Celsion employs 27 workers across the globe.

When was Celsion founded?

Celsion was founded in 1982.

How can I contact Celsion?

Celsion's mailing address is 997 LENOX DRIVE SUITE 100, LAWRENCEVILLE NJ, 08648. The official website for Celsion is www.celsion.com. The biotechnology company can be reached via phone at (609) 896-9100, via email at [email protected], or via fax at 609-896-2200.

This page (NASDAQ:CLSN) was last updated on 6/30/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.